Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Zimmer Biomet Holdings, Inc. (ZBH)
Market Closed
17 Jul, 20:00
NYSE
All
(10)
DE
(5)
AT
(1)
CH
(1)
IT
(1)
MX
(1)
US
(1)
NYSE
Primary
XWBO
SIX
XMEX
XSTU
XHAN
XFRA
XDUS
XMUN
XMIL
$
91.
12
-2.63
-2.8053%
$
17.67B
Market Cap
24.97
P/E Ratio
0.96%
Div Yield
2.63M
Volume
8.06
Eps
$
93.75
Previous Close
Investors:
DI
TMB
CE
PER
+195
Watching
Watch
Add Transaction
Day Range
90.94
93.71
Year Range
79.12
108.29
Want to track
ZBH
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Earnings
Splits
Statistics
News
Historical Data
Investors
Zimmer Biomet Holdings, Inc. (ZBH) Statistics
Valuation metrics
Market Cap
17.67B
Enterprise value
24.68B
Trailing P/E (ttm)
23.55
Forward P/E
10.35
PEG ratio
-1.62
Price/Sales (ttm)
2.1
Price/Book (mrq)
1.4
Enterprise Value/Revenue
2.93
Enterprise Value/EBITDA
11.18
Overview
Shares outstanding
195.48M
Float
195.06M
Shares short
7.69M
% Held by insiders
0%
% Held by institutions
1.04%
Average volume (10 days)
2.39M
Average volume (90 days)
2.62M
Price summary
52-Week low
79.12
52-Week high
108.29
Beta
0.59
50-Day moving average
90.06
200-Day moving average
90.15
Dividends and splits
Forward annual dividend rate
0.96
Forward annual dividend yield
0.0103%
Trailing annual dividend rate
0.96
Trailing annual dividend yield
0.0105%
5-Year annual dividend yield
0.82%
Payout ratio
0.25
Dividend Date
30 Apr 2026
Ex-Dividend Date
31 Mar 2026
Last split factor
103:100
Last split Date
1 Mar 2022
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
31 Dec 2025
Profitability
Profit margin
0.09%
Operating margin
0.16%
Operational effectiveness
Return on assets
0.03%
Return on equity
0.06%
Income Statement
Revenue (ttm)
8.23B
Revenue per share (ttm)
43.12
Quarterly revenue growth (yoy)
0.11%
Gross profit (ttm)
5.74B
EBITDA
2.48B
Net income to common (ttm)
705.1M
Diluted EPS (ttm)
3.9
Quarterly earnings growth (yoy)
-0.42%
Balance Sheet
Total cash (mrq)
620.9M
Total cash per share (mrq)
2.18
Total debt (mrq)
7.87B
Total Debt/Equity (mrq)
0.59
Current ratio (mrq)
1.73%
Book value per share (mrq)
65.03
Cash Flow
Cash flow statement
1.7B
Levered free cash flow (LFCF)
1.35B